Colin Rom

More About Colin

Colin Rom is the public policy lead for Bio + Health, building a16z into a leading voice of health innovation in Washington, D.C.

Prior to joining Andreessen Horowitz, Colin was the Managing Director of Science and Innovation Policy at Mayo Clinic, leading federal engagement strategy for policies focused on artificial intelligence, emerging biotechnology, and next generation care delivery. Before Mayo, Colin spent two years as a policy advisor in the Commissioner’s Office at the U.S. Food and Drug Administration, first as a policy advisor leading several agency-wide initiatives, and subsequently as the Senior Advisor to the Commissioner of Food and Drugs, serving as a liaison between the FDA and White House Coronavirus Task Force and was a member of Operation Warp Speed. He also spent time as a policy and political advisor to the Director of Health Programs at the White House Office of Management and Budget and several years as a health policy advisor in the United States Senate, working for Senator Richard Burr (N.C.) and the Senate Committee on Health, Education, Labor, and Pensions.

Colin graduated from the University of Mary Washington and is currently pursuing his M.S. in Biotechnology Enterprise and Entrepreneurship from Johns Hopkins University. He is a native of Cary, North Carolina and enjoys golf and travel in his free time.